Integra LifeSciences to Present at Three Conferences in March
Raymond James Institutional Investors Conference
Canaccord Adams Musculoskeletal Conference
Barclays Capital Healthcare Conference
PLAINSBORO, N.J., March 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at three conferences in March.
On Monday, March 8th, 2010 at 4:00 pm ET, Mr. John B. Henneman, III, Executive Vice President and Chief Financial Officer of Integra, will present at the Raymond James Institutional Investors Conference in Orlando, Florida. A live webcast will be available for this conference.
On Tuesday, March 9th, 2010 at 11:20 am CT, Mr. Gerry Carlozzi, Executive Vice President and Chief Operations Officer of Integra, will present at the Canaccord Adams Musculoskeletal Conference in New Orleans, Louisiana. A live webcast will also be available for this conference.
On Wednesday, March 24th, 2010 at 8:00 am ET, Mr. Stuart Essig, President and CEO of Integra, will present at the Barclays Capital Healthcare Conference in Miami, Florida. This conference will not be webcast.
For the two live audio webcasts, a link will be available on the investor relations section on our corporate website – www.integra-LS.com. Each webcast will be archived after the live event.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. Our products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. For more information, visit www.Integra-LS.com.
Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2009 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
IART-G
CONTACT: Integra LifeSciences Holdings Corporation
John B. Henneman, III, Executive Vice President,
Finance and Administration and Chief Financial Officer
(609) 275-0500
jhenneman@Integra-LS.com
Investor Relations:
Angela Steinway
(609) 936-2268
angela.steinway@Integra-LS.com(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.